Promising Study Results for Diabetic Kidney Disease Seen with Mesoblast’s Cell Therapy
News
Mesoblast recently announced positive results from the placebo-controlled Phase 2 trial of its cell therapy MPC-300-IV for diabetic kidney disease patients. All results can be found in the paper “Allogeneic Mesenchymal Precursor ... Read more